(MedPage Today) — The CDC’s newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger than 8 months receiving clesrovimab (Enflonsia) to prevent respiratory syncytial virus (RSV).
While lawmakers…
Source link : https://www.medpagetoday.com/pediatrics/rsv/116277
Author :
Publish date : 2025-06-26 21:39:00
Copyright for syndicated content belongs to the linked Source.
